World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
135
Citations
79642
World Ranking
190
National Ranking
20

Medicine

D-Index
135
Citations
79773
World Ranking
2044
National Ranking
213

Ian D. Pavord publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ian D. Pavord sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 770 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ian D. Pavord D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ian D. Pavord sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 135 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Ian D. Pavord is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on medicine, with significant contributions to pulmonary and respiratory medicine, physiology, immunology, surgery, and immunology and allergy.

The scientist's most frequent research topics include:

  • Asthma and respiratory diseases
  • Respiratory and cough-related research
  • Chronic Obstructive Pulmonary Disease (COPD) research
  • IL-33, ST2, and ILC pathways
  • Inhalation and respiratory drug delivery
  • Eosinophilic esophagitis
  • Allergic rhinitis and sensitization

Among recent papers, notable publications are:

  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, European Respiratory Journal
  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, American Journal of Respiratory and Critical Care Medicine
  • Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people, 2020, Heart
  • Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma, 2021, New England Journal of Medicine
  • Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study, 2021, The Lancet Respiratory Medicine

The scientist frequently collaborates with other researchers, including:

  • Alberto Papi
  • Simon Couillard
  • Richard Beasley
  • Christopher E. Brightling
  • Liam G. Heaney

Common publication venues where Ian D. Pavord has appeared include:

  • Journal of Allergy and Clinical Immunology
  • American Journal of Respiratory and Critical Care Medicine
  • The Journal of Allergy and Clinical Immunology In Practice
  • European Respiratory Journal
  • CHEST Journal

Ian D. Pavord has also contributed to book publications with the European Respiratory Society, including works titled "Type 2 biomarkers and assessment of risk" and "Introduction," both expected in 2025.

Among professional recognitions, the scientist is a Fellow of The Academy of Medical Sciences in the United Kingdom.

Best Publications

  • Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

    Ian D Pavord;Stephanie Korn;Peter Howarth;Eugene R Bleecker

  • Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

    Hector G. Ortega;Mark C. Liu;Ian D. Pavord;Guy G. Brusselle

  • Cluster analysis and clinical asthma phenotypes.

    Pranab Haldar;Ian D. Pavord;Dominic E. Shaw;Michael A. Berry

  • Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

    Pranabashis Haldar;Christopher E. Brightling;Beverley Hargadon;Sumit Gupta

  • Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

    Ruth H Green;Christopher E Brightling;Susan McKenna;Beverley Hargadon

  • Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

    Dave Singh;Alvar Agusti;Antonio Anzueto;Peter J. Barnes

  • Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Mario Castro;Jonathan Corren;Ian D. Pavord;Jorge Maspero

  • An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

    Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet

  • Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

    Elisabeth H. Bel;Sally E. Wenzel;Philip J. Thompson;Charlene M. Prazma

  • Mast-Cell Infiltration of Airway Smooth Muscle in Asthma

    Christopher E. Brightling;Peter Bradding;Fiona A. Symon;Stephen T. Holgate

  • British guideline on the management of asthma: A national clinical guideline

    Graham Douglas;Bernard Higgins;Neil Barnes;Anne Boyter

  • Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers

    Mona Bafadhel;Susan McKenna;Sarah Terry;Vijay Mistry

  • Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)

    S S Birring;B Prudon;A J Carr;S J Singh

  • Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

    R H Green;C E Brightling;G Woltmann;D Parker

  • After asthma: redefining airways diseases

    Ian D Pavord;Richard Beasley;Alvar Agusti;Gary P Anderson

  • Evidence of a role of tumor necrosis factor alpha in refractory asthma.

    Mike A. Berry;Beverley Hargadon;Maria Shelley;Debbie Parker

  • Treatable traits: toward precision medicine of chronic airway diseases.

    Alvar Agusti;Elisabeth Bel;Mike Thomas;Claus Vogelmeier

  • Prevalence, pathogenesis, and causes of chronic cough

    Kian Fan Chung;Ian D Pavord

  • Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: A multicenter, randomized, double-blind, sham-controlled clinical trial

    Mario Castro;Adalberto S. Rubin;Michel Laviolette;Jussara Fiterman

  • Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

    Steven Pascoe;Nicholas Locantore;Mark T Dransfield;Mark T Dransfield;Neil C Barnes;Neil C Barnes

Frequent Co-Authors

Christopher E. Brightling
Christopher E. Brightling University of Leicester
Andrew J. Wardlaw
Andrew J. Wardlaw University of Leicester
Peter Bradding
Peter Bradding University of Leicester
David Price
David Price University of Aberdeen
Alberto Papi
Alberto Papi University of Ferrara
Andrew Bush
Andrew Bush Imperial College London
Neil Barnes
Neil Barnes GlaxoSmithKline (United Kingdom)
Anne E. Tattersfield
Anne E. Tattersfield University of Nottingham
Richard Beasley
Richard Beasley Medical Research Institute of New Zealand
Alan J. Knox
Alan J. Knox University of Nottingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals transition into specialized roles through targeted programs. For instance, nurses looking to advance can explore acnp programs that focus on acute care, blending clinical expertise with specialized knowledge.

Accelerated degree options are especially appealing for those seeking faster pathways. Students can consider accelerated np programs online, which offer the flexibility to study while balancing other commitments. These programs cater to individuals who want to expedite their training without compromising quality.

For non-nurses interested in entering the field, online rn programs for non nurses in florida provide accessible entry points into nursing careers. Such degrees often combine foundational coursework with clinical practice, preparing students for immunology-related healthcare roles.

Additionally, those beginning their nursing journey might find it helpful to explore the easiest absn program to get into. These programs are designed to reduce barriers to entry, making nursing education more attainable for many.

Best Scientists Citing Ian D. Pavord

Trending Scientists

Recently Published Articles